|
No records
|
|
528 |
57210795916 |
Melani Marissa |
dr. Melani Marissa, Sp.K.K. |
Departemen Ilmu Kesehatan Kulit dan Kelamin |
|
Characteristics of grade 2 disability in indonesian children with leprosy: A five-year multicenter retrospective study |
Gunawan H., Kamilia A., Menaldi S.L., Marissa M., Prakoeswa C.R.S., Alinda M.D., Widasmara D., Basuki S., Anum Q., Ariani T., Mamuaja E.H., Rusyati L.M.M. |
Clinical, Cosmetic and Investigational Dermatology |
|
Q2 |
|
|
|
601 |
57210795916 |
Melani Marissa |
dr. Melani Marissa, Sp.K.K. |
Departemen Ilmu Kesehatan Kulit dan Kelamin |
|
Evaluation of modified melasma area and severity index in hyperthyroid patients receiving anti-thyroid drugs |
Sitohang I.B.S., Nelson B., Marissa M., Indriatmi W., Wisnu W. |
Open Access Macedonian Journal of Medical Sciences |
|
Q3 |
|
|
|
653 |
57210795916 |
Melani Marissa |
dr. Melani Marissa, Sp.K.K. |
Departemen Ilmu Kesehatan Kulit dan Kelamin |
|
A comparative study of melasma severity after hyperthyroid therapy in hyperthyroid subjects with melasma |
Nelson B., Sitohang I.B.S., Marissa M., Indriatmi W., Wisnu W. |
Acta Dermatovenerologica Alpina, Pannonica et Adriatica |
|
#N/A |
|
|
|
No records
|
|
2 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
High stat5a expression is associated with major molecular response achievement failure of chronic phase chronic myeloid leukemia patients receiving hydroxyurea before imatinib: A cross-sectional study |
Rinaldi I., Putri A., Louisa M., Koesnoe S. |
Open Access Macedonian Journal of Medical Sciences |
|
Q3 |
|
|
|
159 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
Safety and Pharmacokinetic Profiles of Long-Acting Injectable Antiretroviral Drugs for HIV-1 Pre-Exposure Prophylaxis: A Systematic Review and Meta-analysis of Randomized Trials |
Lazarus G., Wangsaputra V.K., Christianto, Louisa M., Soetikno V., Hamers R.L. |
Frontiers in Pharmacology |
|
Q1 |
|
|
|
218 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
Alpha-mangostin Reduces Cell Viability in Sorafenib-surviving Cells by Modulating Multiple Drug Transporters in Hepg2 Hepatocellular Carcinoma Cells |
Wangsaputra V.K., Syarinta S., Louisa M. |
Journal of Applied Pharmaceutical Science |
|
Q2 |
|
|
|
325 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
The potential of gallic acid as a radiosensitizer on human prostate cancer: A systematic review of preclinical studies |
Cahyono A.T., Louisa M., Mayang Permata T.B., Handoko, Nuryadi E., Kodrat H., Wibowo H., Hariandy Hamid A.R.A., Sekarutami S.M., Gondhowiardjo S.A. |
Malaysian Journal of Medicine and Health Sciences |
|
Q4 |
|
|
|
393 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
The effect of human immunodeficiency virus infection on adverse events during treatment of drug-resistant tuberculosis: A systematic review and meta-analysis |
Lazarus G., Tjoa K., Iskandar A.W.B., Louisa M., Sagwa E.L., Padayatchi N., Soetikno V. |
PLoS ONE |
|
Q1 |
|
|
|
431 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
Role of TGF-?1 in human breast cancer stem cells |
Hariyanto N.I., Purwandhita R.P., Syahrani R.A., Louisa M., Wanandi S.I. |
Journal of the Pakistan Medical Association |
1 |
Q4 |
|
|
